Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company is seeking a Senior Corporate Counsel, Contracts (Clinical Development) to support clinical research and development activities, drafting, negotiating, and advising on clinical and research-related agreements.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
Capricor Therapeutics, Inc.